Literature DB >> 23528194

Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.

Nancy M Petry1, Kathleen M Carroll2.   

Abstract

Contingency management (CM) is an empirically supported intervention for substance dependence, but it has not been evaluated systematically in non maintained opioid-dependent patients. This retrospective analysis examined whether CM was effective in opioid-dependent patients initiating intensive outpatient psychosocial treatment. In the primary trial (Petry, N. M., Weinstock, J., & Alessi, S. M. [2011]. A randomized trial of contingency management delivered in the context of group counseling. Journal of Consulting and Clinical Psychology, 79, 686-696), substance-abusing patients (n = 239) at two community-based clinics were randomized to standard care (SC) or SC with CM for 12 weeks; in the CM condition, patients earned opportunities to win prizes for attending treatment and submitting drug-negative samples. For this analysis, patients were further classified as non-opioid-dependent (n = 159), opioid-dependent and not receiving maintenance therapy (n = 33), or opioid-dependent and on methadone or Suboxone maintenance therapy (n = 47). Main effects of opioid dependence/maintenance status, treatment condition, and their interaction were evaluated with respect to attendance and abstinence outcomes. Opioid-dependent patients receiving maintenance pharmacotherapy attended treatment on fewer days and achieved less abstinence than their opioid-dependent counterparts who were not on opioid agonist therapy, with Cohen's d effect sizes of 0.63 and 0.61 for attendance and abstinence outcomes, respectively. Nonmaintained opioid-dependent patients evidenced similar outcomes as substance abusing patients who were not opioid-dependent. CM also improved retention and abstinence (d = .26 and .40, respectively), with no interaction effects with opioid dependence/maintenance status noted. These data suggest that CM may be an effective psychosocial intervention potentially suitable for the growing population of opioid-dependent patients, including those not receiving maintenance pharmacotherapy. PsycINFO Database Record (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23528194      PMCID: PMC4110951          DOI: 10.1037/a0032175

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  40 in total

1.  Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude.

Authors:  Kathleen M Carroll; Rajita Sinha; Charla Nich; Theresa Babuscio; Bruce J Rounsaville
Journal:  Exp Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.157

2.  Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Authors:  K M Carroll; S A Ball; C Nich; P G O'Connor; D A Eagan; T L Frankforter; E G Triffleman; J Shi; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2001-08

3.  Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification.

Authors:  Michelle Tuten; Anthony DeFulio; Hendrée E Jones; Maxine Stitzer
Journal:  Addiction       Date:  2012-02-28       Impact factor: 6.526

4.  Initial abstinence and success in achieving longer term cocaine abstinence.

Authors:  S T Higgins; G J Badger; A J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.157

5.  Predictive validity of the Addiction Severity Index's composite scores in the assessment of 2-year outcomes in a methadone maintenance population.

Authors:  G B Bovasso; A I Alterman; J S Cacciola; T G Cook
Journal:  Psychol Addict Behav       Date:  2001-09

6.  Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation.

Authors:  K Gruber; M A Chutuape; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  2000-01-01       Impact factor: 4.492

7.  Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.

Authors:  Nancy M Petry; Bonnie Martin
Journal:  J Consult Clin Psychol       Date:  2002-04

8.  Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.

Authors:  Elizabeth C Katz; Mary Ann Chutuape; Hendree E Jones; Maxine L Stitzer
Journal:  Exp Clin Psychopharmacol       Date:  2002-05       Impact factor: 3.157

9.  Community reinforcement therapy for cocaine-dependent outpatients.

Authors:  Stephen T Higgins; Stacey C Sigmon; Conrad J Wong; Sarah H Heil; Gary J Badger; Robert Donham; Robert L Dantona; Stacey Anthony
Journal:  Arch Gen Psychiatry       Date:  2003-10

10.  Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.

Authors:  Thomas Kosten; Alison Oliveto; Alan Feingold; James Poling; Kevin Sevarino; Elinore McCance-Katz; Susan Stine; Gerardo Gonzalez; Kishor Gonsai
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

View more
  7 in total

1.  Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  J Dual Diagn       Date:  2014

2.  Emerging adult age status predicts poor buprenorphine treatment retention.

Authors:  Zev Schuman-Olivier; Roger D Weiss; Bettina B Hoeppner; Jacob Borodovsky; Mark J Albanese
Journal:  J Subst Abuse Treat       Date:  2014-05-20

Review 3.  New developments in behavioral treatments for substance use disorders.

Authors:  Brian D Kiluk; Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users.

Authors:  Sterling L Karakula; Roger D Weiss; Margaret L Griffin; Allison M Borges; Allen J Bailey; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2016-10-17       Impact factor: 4.492

5.  Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial.

Authors:  André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Claudio J da Silva; Sterling McPherson; John M Roll; Ronaldo R Laranjeira
Journal:  Psychol Addict Behav       Date:  2016-07-21

Review 6.  Lost in translation? Moving contingency management and cognitive behavioral therapy into clinical practice.

Authors:  Kathleen M Carroll
Journal:  Ann N Y Acad Sci       Date:  2014-09-09       Impact factor: 5.691

7.  Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies.

Authors:  David A Wohl; Andrew G Allmon; Donna Evon; Christopher Hurt; Sarah Ailleen Reifeis; Harsha Thirumurthy; Becky Straub; Angela Edwards; Katie R Mollan
Journal:  Open Forum Infect Dis       Date:  2017-05-05       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.